Your session is about to expire
← Back to Search
Buprenorphine + Patient Navigation for Opioid Use Disorder (OUTLAST-B Trial)
OUTLAST-B Trial Summary
This trial will compare different ways of helping people with opioid addiction get treatment, to see which is most effective.
OUTLAST-B Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOUTLAST-B Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 815 Patients • NCT01675167OUTLAST-B Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any unstable medical or mental health conditions.I am allergic to buprenorphine or naloxone, or I am on chronic opioid pain medication.I regularly use long-acting opioids like methadone.I am 18 years old or older.I am willing to try buprenorphine treatment.I understand the details of the clinical trial and can give informed consent.
- Group 1: Usual Care (UC)
- Group 2: Patient Navigation (PN)
- Group 3: Patient Navigation + Buprenorphine Initiation (PN+BUP)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people with the condition are being welcomed into this clinical trial?
"Unfortunately, this particular clinical trial is no longer enrolling patients. The study was originally posted on September 17th 2021 but has not been updated since December 15th of the same year. However, there are 552 other trials concerning opioid abuse and 60 studies involving Buprenorphine that are actively recruiting participants."
What conditions does Buprenorphine commonly treat?
"Buprenorphine can help patients manage pain, opioids, and pruritus."
Are there other examples of Buprenorphine research?
"Currently, there are 60 different clinical trials studying Buprenorphine. Out of those active investigations, 14 have progressed to Phase 3 testing. Many of the trials originate from White River Junction, Vermont; however, Buprenorphine is being studied in 243 distinct locations."
Are there any slots still available for participants in this trial?
"Presently, this study is not recruiting patients due to a complete enrolment of subjects. The trial was first posted on September 17th, 2021 and last updated on December 15th, 2021. There are other clinical trials studying similar topics that may be actively recruiting participants; 552 studies for opioid abuse and 60 for Buprenorphine."
Share this study with friends
Copy Link
Messenger